Literature DB >> 20818206

The neural mechanism for Latent (fusion maldevelopment) nystagmus.

Lawrence Tychsen1, Michael Richards, Agnes Wong, Paul Foeller, Dolores Bradley, Andreas Burkhalter.   

Abstract

Latent nystagmus (LN) is the by-product of fusion maldevelopment in infancy. Because fusion maldevelopment--in the form of strabismus and amblyopia--is common, LN is a prevalent form of pathologic nystagmus encountered in clinical practice. It originates as an afferent visual pathway disorder. To unravel the mechanism for LN, we studied patients and nonhuman primates with maldeveloped fusion. These experiments have revealed that loss of binocular connections within striate cortex (area V1) in the first months of life is the necessary and sufficient cause of LN. The severity of LN increases systematically with longer durations of binocular decorrelation and greater losses of V1 connections. Decorrelation durations that exceed the equivalent of 2-3 months in human development result in an LN prevalence of 100%. No manipulation of brain stem motor pathways is required. The binocular maldevelopment originating in area V1 is passed on to downstream extrastriate regions of cerebral cortex that drive conjugate gaze, notably MSTd. Conjugate gaze is stable when MSTd neurons of the right and left cerebral hemispheres have balanced binocular activity. Fusion maldevelopment in infancy causes unbalanced monocular activity. If input from one eye dominates and the other is suppressed, MSTd in one hemisphere becomes more active. Acting through downstream projections to the ipsilateral nucleus of the optic tract, the eyes are driven conjugately to that side. The unbalanced MSTd drive is evident as the nasalward gaze-holding bias of LN when viewing with either eye.

Entities:  

Mesh:

Year:  2010        PMID: 20818206     DOI: 10.1097/WNO.0b013e3181dfa9ca

Source DB:  PubMed          Journal:  J Neuroophthalmol        ISSN: 1070-8022            Impact factor:   3.042


  18 in total

1.  Strabismus and the Oculomotor System: Insights from Macaque Models.

Authors:  Vallabh E Das
Journal:  Annu Rev Vis Sci       Date:  2016-07-18       Impact factor: 6.422

Review 2.  Fellow Eye Deficits in Amblyopia.

Authors:  Eileen E Birch; Krista R Kelly; Deborah E Giaschi
Journal:  J Binocul Vis Ocul Motil       Date:  2019-06-04

3.  Fixation instability in anisometropic children with reduced stereopsis.

Authors:  Eileen E Birch; Vidhya Subramanian; David R Weakley
Journal:  J AAPOS       Date:  2013-06       Impact factor: 1.220

4.  Comparison of Naso-temporal Asymmetry During Monocular Smooth Pursuit, Optokinetic Nystagmus, and Ocular Following Response in Strabismic Monkeys.

Authors:  Anand C Joshi; Mehmet N Agaoglu; Vallabh E Das
Journal:  Strabismus       Date:  2017-05-02

5.  Fixation control and eye alignment in children treated for dense congenital or developmental cataracts.

Authors:  Eileen E Birch; Jingyun Wang; Joost Felius; David R Stager; Richard W Hertle
Journal:  J AAPOS       Date:  2012-04       Impact factor: 1.220

6.  A quantitative study of fixation stability in amblyopia.

Authors:  Vidhya Subramanian; Reed M Jost; Eileen E Birch
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-03-19       Impact factor: 4.799

Review 7.  Amblyopia and binocular vision.

Authors:  Eileen E Birch
Journal:  Prog Retin Eye Res       Date:  2012-11-29       Impact factor: 21.198

8.  Motion Information via the Nonfixating Eye Can Drive Optokinetic Nystagmus in Strabismus.

Authors:  Sevda Agaoglu; Mehmet N Agaoglu; Vallabh E Das
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-10       Impact factor: 4.799

9.  Fixation eye movement abnormalities and stereopsis recovery following strabismus repair.

Authors:  Talora L Martin; Jordan Murray; Kiran Garg; Charles Gallagher; Aasef G Shaikh; Fatema F Ghasia
Journal:  Sci Rep       Date:  2021-07-13       Impact factor: 4.379

Review 10.  Nystagmus in pediatric patients: interventions and patient-focused perspectives.

Authors:  Kimberly Penix; Mark W Swanson; Dawn K DeCarlo
Journal:  Clin Ophthalmol       Date:  2015-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.